A pre-translational defect in a case of human mu heavy chain disease.
A patient (BW) was studied with Mu heavy chain disease (mu HCD) in whom a leukemic B-cell clone secreted a shortened monoclonal mu chain without associated light chain. The cells did, however, produce a normal-sized kappa light chain that was detected as urinary Bence-Jones protein. The cytoplasmic and secreted monomeric mu chain had an approximate mol. wt of 58,000. Radiochemical sequence analysis of the biosynthetically labelled mu chain revealed a protein that lacked the entire variable region. The sequence initiated at amino acid position 5 within the first constant region domain (CH1) of C mu. The primary in vitro translation product, the cytoplasmic and secreted proteins were all similarly truncated, thereby excluding extensive postsynthetic degradation. The mu RNA, that directed the synthesis of the truncated mu protein, was about 350 bp smaller than the normal mu RNA. Furthermore, by primer extension analysis it was possible to localize this deletion in the mu RNA to a region 5' of CH1. Thus, a defect at the level of Ig gene structure/assembly that deletes coding information or results in aberrant RNA processing must be responsible for the truncated mu HCD protein BW.
D000595:Amino Acid Sequence; D001536:Bence Jones Protein / Q000652:urine; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006362:Heavy Chain Disease / Q000235:genetics*; D006801:Humans; D007122:Immunoelectrophoresis; D007148:Immunoglobulin mu-Chains / Q000096:biosynthesis / Q000235:genetics; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000032:analysis
D007148:Immunoglobulin mu-Chains; D012333:RNA, Messenger; D001536:Bence Jones Protein